New! #ClinicalTrialUpdate from #JCO: Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis ascopubs.org/doi/10.1200/...
#JCOjournals #OpenAccess